Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CMTR-CHEMTRAK FDA OK -- Ignore unavailable to you. Want to Upgrade?

To: surfinSteve who wrote (1095)	6/24/1998 6:26:00 PM
From: Mr. E	Read Replies (2) \| Respond to of 1172

Mea Culpa. I need to lighten up!. I've been holding CMTR since before the IPO (exercised my options). CMTR paid the down on my house (sold a bunch at $12) and it's been sad to see it decline to its present state. I don't know if CMTR is a fit for PFE. PFE is a pharm. They contract with others to develop diagnostics. As far as the finger stick is concerned, There are alot of them around and unless CMTR has got a significantly better, cheaper way of doing it, it may not be worth much. IMO the basic patents on the Accumeter are what make the company's worth. Where's Warren Buffett when you really need him?! LOL Bob E.